AGL 40.00 Decreased By ▼ -0.16 (-0.4%)
AIRLINK 129.53 Decreased By ▼ -2.20 (-1.67%)
BOP 6.68 Decreased By ▼ -0.01 (-0.15%)
CNERGY 4.63 Increased By ▲ 0.16 (3.58%)
DCL 8.94 Increased By ▲ 0.12 (1.36%)
DFML 41.69 Increased By ▲ 1.08 (2.66%)
DGKC 83.77 Decreased By ▼ -0.31 (-0.37%)
FCCL 32.77 Increased By ▲ 0.43 (1.33%)
FFBL 75.47 Increased By ▲ 6.86 (10%)
FFL 11.47 Increased By ▲ 0.12 (1.06%)
HUBC 110.55 Decreased By ▼ -1.21 (-1.08%)
HUMNL 14.56 Increased By ▲ 0.25 (1.75%)
KEL 5.39 Increased By ▲ 0.17 (3.26%)
KOSM 8.40 Decreased By ▼ -0.58 (-6.46%)
MLCF 39.79 Increased By ▲ 0.36 (0.91%)
NBP 60.29 No Change ▼ 0.00 (0%)
OGDC 199.66 Increased By ▲ 4.72 (2.42%)
PAEL 26.65 Decreased By ▼ -0.04 (-0.15%)
PIBTL 7.66 Increased By ▲ 0.18 (2.41%)
PPL 157.92 Increased By ▲ 2.15 (1.38%)
PRL 26.73 Increased By ▲ 0.05 (0.19%)
PTC 18.46 Increased By ▲ 0.16 (0.87%)
SEARL 82.44 Decreased By ▼ -0.58 (-0.7%)
TELE 8.31 Increased By ▲ 0.08 (0.97%)
TOMCL 34.51 Decreased By ▼ -0.04 (-0.12%)
TPLP 9.06 Increased By ▲ 0.25 (2.84%)
TREET 17.47 Increased By ▲ 0.77 (4.61%)
TRG 61.32 Decreased By ▼ -1.13 (-1.81%)
UNITY 27.43 Decreased By ▼ -0.01 (-0.04%)
WTL 1.38 Increased By ▲ 0.10 (7.81%)
BR100 10,407 Increased By 220 (2.16%)
BR30 31,713 Increased By 377.1 (1.2%)
KSE100 97,328 Increased By 1781.9 (1.86%)
KSE30 30,192 Increased By 614.4 (2.08%)

AGP Limited, a Pakistani pharmaceutical company, has acquired a select portfolio of products from American firm Viatris Inc. through a Special Purpose Vehicle (SPV), a move authorised by AGP’s board last year.

The pharma shared the development in a notice to the Pakistan Stock Exchange (PSX) on Friday.

“We are pleased to inform you that after securing requisite approvals, AGP Limited, through a SPV- OBS Pakistan (Private) Limited, has successfully acquired a portfolio of certain pharmaceutical brands from Viatris Inc. which are commercialized in Pakistan primarily under the brands previously owned by Pfizer Inc.,” read the notice.

Viatris was formed in 2020 when pharma company Mylan merged with Upjohn, Pfizer’s off-patent medicine division.

AGP said that the portfolio it has acquired include a broad range of anti-depressants, anti- hypertensive and opthalmogoly products.

It said all the brands are well established with high brand equity and strong customer loyalty, including Zoloft, Cardura, Lyrica and Lipitor. The largest brand in the portfolio is Norvasc, which it said has recorded a turnover of Rs1.3 billion during the last 12 months as per a report issued by IQVIA Solutions Pakistan.

Pakistani pharma aims to acquire Sandoz owned brands to enhance share

The acquisition is expected to result in a significant increase in the consolidated revenues of AGP, which is expected to cross Rs20 billion over the next 12 months.

The company said it will also begin in-house manufacturing of the majority of these brands in due course, which will result in “economies of scale, operational synergies, and logistical efficiencies and in turn, maximizing shareholders’ value.”

AGP is a subsidiary of OBS Pakistan and the ultimate parent company is West End 16 Pte Limited- Singapore.

Last year in June, AGP said that its board has authorised it to acquire a select portfolio of products from Viatris Inc. through a SPV. The company had then said the SPV will acquire the brands through an optimal capital structure comprising equity and debt in the ratio of 25:75.

It also said AGP will own up to 85% shareholding in the SPV.

Comments

Comments are closed.